Investing Profile

David Rubin

VCInvestor
Managing Director, Merck Global Health Innovation Fund; AVP, Merck & Co at Merck Global Health Innovation Fund
msdghifund.comUnited States
Photo of David Rubin, Managing Director at Merck Global Health Innovation Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Medical School Network
67 CONNECTIONS
Harvard Medical School Network
55 CONNECTIONS
Merck Network
52 CONNECTIONS
Merck Network
52 CONNECTIONS
Cardiaccs AS Network
38 CONNECTIONS
cb
$100K - $5.0M
$1.5M
20
CompanyStageDateRound SizeTotal Raised
Turbine
Series BFeb 2026$25M
Series ANov 2022$21M
$160M
Co-investors: Barath Shankar Subramanian (Accel), Alexandre Perrin (Enauto Ventures), Anvesh Ramineni (MassMutual Ventures), Hany Nada (ACME Capital), Daniel Waterhouse (Balderton Capital), Esther Dyson (EPAM Systems), Christian Dahlen (Band of Angels), Vishal Gulati (Molten Ventures), Richard De Silva
Octave
Series CSep 2025$36M
Series BJul 2023$33M
Series UnknownOct 2021
$190M
Co-investors: Mike Pellini (Section 32), Michael Rubin (Northpond Ventures), Julian Harris (Deerfield Management), Brett Queener (Bonfire Ventures), Saurabh Bhansali (Health Velocity Capital), Michael G. Rubin
N-Power Medicine
Series BMay 2024$72M
$72M
Baseimmune
Series AFeb 2024$11M
$17M
Co-investors: Jamie Macfarlane (Creator Fund), Hussein Kanji (Hoxton Ventures)
Culmination Bio
Series ANov 2023$10M
$10M
Co-investors: Jack Boren
PreciseDx
Series AJan 2022$11M
$14M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Verge Genomics
Series BDec 2021$98M
$130M
Co-investors: Lan Xuezhao (Basis Set Ventures), Henry McNamara (Great Oaks Venture Capital), Andrew Boszhardt (Great Oaks Venture Capital), Jesse Beyroutey (IA Ventures), Elad Gil (Gil Capital / Gil & Co), Chris Sklarin (Castor Ventures), Kimberly Vogel Reynik, Kimberly Vogel
Saama
Private EquityOct 2021
Post-Doctoral Fellow Harvard Medical SchoolPresent
Senior Consultant MerativePresent
Director of Franchise and Portfolio Management MerckPresent
Managing Director, Merck Global Health Innovation Fund; AVP, Merck & Co MerckPresent
President, CEO, Director Cardiaccs ASPresent
Temple University Ph.D. Molecular Biology
Harvard Medical School Post-Doctoral Fellow Molecular Biology and Biochemistry
Sign in with Google →
Sign in with Google →